Statement of Ownership (sc 13g)
June 07 2019 - 5:23PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )**
|
Zyla
Life Sciences
|
(Name
of Issuer)
Common
Stock, $.001 par value
|
(Title
of Class of Securities)
28226B302
|
(CUSIP
Number)
May
10, 2019
|
(Date
of Event Which Requires Filing of this Statement)
|
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
☒
|
Rule
13d-1(b)
|
|
☐
|
Rule
13d-1(c)
|
|
☐
|
Rule
13d-1(d)
|
**
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP
No
.
|
28226B302
|
|
Page
2 of 12
|
1
|
NAME
OF REPORTING PERSONS
Riva Ridge Master Fund, Ltd.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 98-0427079
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Cayman
Islands
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING
0
|
|
6
|
SHARED
VOTING POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.2%
|
|
12
|
TYPE
OF REPORTING PERSON
PN
|
|
|
|
|
|
|
*The
information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is
set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference
for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person
is based on 9,360,968 shares of Common Stock issued and outstanding as of May 15, 2019, as represented in the Company’s
Current Report on Form 10-Q Form filed with the Securities and Exchange Commission on May 17, 2019, and assumes, as a
result of the Blocker (as defined below), no exercise by Riva Ridge Master Fund, Ltd. of its warrants to purchase 555,286
shares of Common Stock (the “
Reported Warrants
”).
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent
the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common
Stock (the "
Blocker
"), and the percentage set forth in Row 11 of the cover page for each Reporting Person
gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement,
the Reporting Persons were not able to exercise any of the Reported Warrants due to the Blocker.
|
CUSIP
No
.
|
28226B302
|
|
Page
3 of 12
|
1
|
NAME
OF REPORTING PERSONS
Stephen Golden
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN:
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States of America
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING
0
|
|
6
|
SHARED
VOTING POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.2%
|
|
12
|
TYPE
OF REPORTING PERSON
HC,
IN
|
|
|
|
|
|
|
*The
information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is
set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference
for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person
is based on 9,360,968 shares of Common Stock issued and outstanding as of May 15, 2019, as represented in the Company’s
Current Report on Form 10-Q Form filed with the Securities and Exchange Commission on May 17, 2019, and assumes, as a
result of the Blocker (as defined below), no exercise by Riva Ridge Master Fund, Ltd. of its warrants to purchase 555,286
shares of Common Stock (the “
Reported Warrants
”).
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent
the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common
Stock (the "
Blocker
"), and the percentage set forth in Row 11 of the cover page for each Reporting Person
gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement,
the Reporting Persons were not able to exercise any of the Reported Warrants due to the Blocker.
|
CUSIP
No
.
|
28226B302
|
|
Page
4 of 12
|
1
|
NAME
OF REPORTING PERSONS
James Shim
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN:
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States of America
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING
0
|
|
6
|
SHARED
VOTING POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.2%
|
|
12
|
TYPE
OF REPORTING PERSON
HC,
IN
|
|
|
|
|
|
|
*The
information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is
set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference
for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person
is based on 9,360,968 shares of Common Stock issued and outstanding as of May 15, 2019, as represented in the Company’s
Current Report on Form 10-Q Form filed with the Securities and Exchange Commission on May 17, 2019, and assumes, as a
result of the Blocker (as defined below), no exercise by Riva Ridge Master Fund, Ltd. of its warrants to purchase 555,286
shares of Common Stock (the “
Reported Warrants
”).
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent
the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common
Stock (the "
Blocker
"), and the percentage set forth in Row 11 of the cover page for each Reporting Person
gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement,
the Reporting Persons were not able to exercise any of the Reported Warrants due to the Blocker.
|
CUSIP
No
.
|
28226B302
|
Page 5
of 12
|
1
|
NAME
OF REPORTING PERSONS
Riva Ridge Capital Management LP
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 61-1446145
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware,
United States of America
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING
0
|
|
6
|
SHARED
VOTING POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.2%
|
|
12
|
TYPE
OF REPORTING PERSON
HC,
IA, PN
|
|
|
|
|
|
|
*The
information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is
set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference
for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person
is based on 9,360,968 shares of Common Stock issued and outstanding as of May 15, 2019, as represented in the Company’s
Current Report on Form 10-Q Form filed with the Securities and Exchange Commission on May 17, 2019, and assumes, as a
result of the Blocker (as defined below), no exercise by Riva Ridge Master Fund, Ltd. of its warrants to purchase 555,286
shares of Common Stock (the “
Reported Warrants
”).
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent
the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common
Stock (the "
Blocker
"), and the percentage set forth in Row 11 of the cover page for each Reporting Person
gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement,
the Reporting Persons were not able to exercise any of the Reported Warrants due to the Blocker.
|
CUSIP
No
.
|
28226B302
|
Page 6
of 12
|
1
|
NAME
OF REPORTING PERSONS
Riva Ridge GP LLC
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS
(ENTITIES ONLY) EIN: 61-1446144
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
☐
(b)
☒
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware,
United States of America
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
5
|
SOLE
VOTING
0
|
|
6
|
SHARED
VOTING POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
7
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
SHARED
DISPOSITIVE POWER
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,238,661
shares of Common Stock; plus 555,286 shares of Common Stock issuable upon the exercise of Warrants (subject to the terms
thereof)*
|
|
10
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
|
☐
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
13.2%
|
|
12
|
TYPE
OF REPORTING PERSON
HC,
OO
|
|
|
|
|
|
|
*The
information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is
set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference
for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person
is based on 9,360,968 shares of Common Stock issued and outstanding as of May 15, 2019, as represented in the Company’s
Current Report on Form 10-Q Form filed with the Securities and Exchange Commission on May 17, 2019, and assumes, as a
result of the Blocker (as defined below), no exercise by Riva Ridge Master Fund, Ltd. of its warrants to purchase 555,286
shares of Common Stock (the “
Reported Warrants
”).
Pursuant to the terms of the Reported Warrants, the Reporting Persons cannot exercise the Reported Warrants to the extent
the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common
Stock (the "
Blocker
"), and the percentage set forth in Row 11 of the cover page for each Reporting Person
gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement,
the Reporting Persons were not able to exercise any of the Reported Warrants due to the Blocker.
|
CUSIP
No
.
|
28226B302
|
|
Page
7 of 12
|
Item
1(a).
|
|
Name of Issuer:
Zyla Life Sciences
(the “Issuer”)
|
|
|
|
|
|
|
Item
1(b).
|
|
Address
of Issuer’s Principal Executive Offices:
600
Lee Road, Suite 100
Wayne, Pennsylvania 19087
|
|
|
|
|
|
|
Item
2(a).
|
|
Name
of Person Filing:
This
statement is jointly filed by and on behalf of each of Riva Ridge Master Fund, Ltd. (the “
Master Fund
”),
Stephen Golden (“
Golden
”), James Shim (“
Shim
”), Riva Ridge Capital Management LP
(“
RRCM
”), and Riva Ridge GP LLC (“
RRGP
” and, together with the Master Fund, Golden,
Shim and RRCM, the “
Reporting Persons
”).
The
Master Fund is the record and direct owner of the Issuer securities covered by this statement. RRCM, as the investment
manager of the Master Fund, may be deemed to beneficially own the Issuer securities owned by the Master Fund. RRGP, as
the general partner of RRCM, may be deemed to beneficially own the Issuer securities owned by the Master Fund. Each of
Golden and Shim, as a managing member of RRGP with the power to exercise investment discretion, may be deemed to beneficially
own the Issuer securities owned by the Master Fund.
Each
Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission
that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner
of any securities covered by this statement.
Each
of the Reporting Persons may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer
for the purposes of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing
of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section
13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other
person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing
of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of
any group with respect to the Issuer or any securities of the Issuer.
|
|
|
|
Item
2(b).
|
|
Address
of Principal Business Office or, if None, Residence:
|
|
|
The
address of the principal business office of each of the Reporting Persons is 55 Fifth Avenue, New York, NY 10003.
|
|
|
|
Item
2(c).
|
|
Citizenship:
|
|
|
See
Item 4 on the cover page(s) hereto.
|
|
|
|
Item
2(d).
|
|
Title
of Class of Securities:
|
|
|
See
the cover page of this filing.
|
|
|
|
Item
2(e).
|
|
CUSIP
Number: 28226B302
|
|
|
|
|
|
|
Item
3.
|
If
This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
|
|
|
|
(a)
|
☐
|
Broker
or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
(b)
|
☐
|
Bank
as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(c)
|
☐
|
Insurance
company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
(d)
|
☐
|
Investment
company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
(e)
|
☒
|
An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
CUSIP
No
.
|
28226B302
|
|
Page
8 of 12
|
|
(f)
|
☐
|
An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
☒
|
A
parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
|
|
|
|
|
|
(h)
|
☐
|
A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
☐
|
A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act (15 U.S.C. 80a-3);
|
|
|
|
|
|
(j)
|
☐
|
Group,
in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
Item
4.
|
Ownership.
|
|
|
|
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified
in Item 1.
|
|
|
|
(a)
|
Amount
beneficially owned: See Item 9 on the cover page(s) hereto.
|
|
|
|
|
|
|
|
|
|
|
(b)
|
Percent
of class: See Item 11 on the cover page(s) hereto.
|
|
|
|
|
|
|
|
|
|
|
(c)
|
Number
of shares as to which such person has:
|
|
|
|
|
|
(i)
|
Sole
power to vote or to direct the vote: See Item 5 on the cover page(s) hereto.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(ii)
|
Shared
power to vote or to direct the vote: See Item 6 on the cover page(s) hereto.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iii)
|
Sole
power to dispose or to direct the disposition of: See Item 7 on the cover page(s) hereto.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(iv)
|
Shared
power to dispose or to direct the disposition of: See Item 8 on the cover page(s) hereto.
|
|
|
|
|
CUSIP
No
.
|
28226B302
|
|
Page
9 of 12
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
|
|
|
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following ☐
|
|
|
Item 6.
|
Ownership of
More than Five Percent on Behalf of Another Person.
|
|
Not applicable
|
|
|
|
|
Item 7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control
Person.
|
|
Not applicable
|
|
|
|
|
Item 8.
|
Identification
and Classification of Members of the Group.
|
|
Not applicable
|
|
|
|
|
Item 9.
|
Notice of Dissolution
of Group.
|
|
Not applicable
|
|
|
|
|
Item 10.
|
Certification.
|
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held
in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
Dated:
|
June
7, 2019
|
|
|
|
Riva
Ridge Master Fund, Ltd.
By:
Riva Ridge Capital Management LP
Its
Investment Adviser
By:
Riva Ridge GP LLC
Its
General Partner
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
|
Riva
Ridge Capital Management LP
|
|
|
|
By:
Riva Ridge GP LLC
Its
General Partner
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
Page
10 of 12
|
|
|
|
Riva
Ridge GP LLC
|
|
|
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
Stephen
Golden
|
|
/s/
Stephen Golden
|
|
James
Shim
|
|
|
|
/s/
James Shim
|
|
|
|
Page
11 of 12
EXHIBIT
INDEX
EXHIBIT
1:
|
Joint Acquisition Statement Pursuant to Section 240.13d-1(k)
|
Page
12 of 12
EXHIBIT
1
JOINT
ACQUISITION STATEMENT
PURSUANT
TO SECTION 240.13d-1(k)
The
undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and
that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the
necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible
for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained
therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons,
except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
Dated:
June 7, 2019
Dated:
|
June
7, 2019
|
|
|
|
Riva
Ridge Master Fund, Ltd.
By:
Riva Ridge Capital Management LP
Its
Investment Advisor
By:
Riva Ridge GP LLC
Its
General Partner
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
|
Riva
Ridge Capital Management LP
|
|
|
|
By:
Riva Ridge GP LLC
Its
General Partner
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
Riva
Ridge GP LLC
|
|
|
|
|
Signature:
|
/s/
Stephen Golden
|
|
Name:
|
Stephen
Golden
|
|
Title:
|
Managing
Member
|
|
|
|
Stephen
Golden
|
|
/s/
Stephen Golden
|
|
James
Shim
|
|
|
|
/s/
James Shim
|
|
|
|
|